343 related articles for article (PubMed ID: 8728196)
21. Impact of Assisted Peritoneal Dialysis Modality on Outcomes: A Cohort Study of the French Language Peritoneal Dialysis Registry.
Guilloteau S; Lobbedez T; Guillouët S; Verger C; Ficheux M; Lanot A; Béchade C
Am J Nephrol; 2018; 48(6):425-433. PubMed ID: 30463079
[TBL] [Abstract][Full Text] [Related]
22. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
Sanchez AR; Madonia C; Rascon-Pacheco RA
Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
[TBL] [Abstract][Full Text] [Related]
23. Continuous ambulatory peritoneal dialysis in patients with hepatitis B liver disease.
Chow KM; Szeto CC; Wu AK; Leung CB; Kwan BC; Li PK
Perit Dial Int; 2006; 26(2):213-7. PubMed ID: 16623428
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement.
Jo YI; Song JO; Park JH; Lee JH; Shin SK
Nephrology (Carlton); 2007 Oct; 12(5):437-40. PubMed ID: 17803465
[TBL] [Abstract][Full Text] [Related]
25. Dialysate leaks in peritoneal dialysis.
Leblanc M; Ouimet D; Pichette V
Semin Dial; 2001; 14(1):50-4. PubMed ID: 11208040
[TBL] [Abstract][Full Text] [Related]
26. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
Cameron JS
Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
[TBL] [Abstract][Full Text] [Related]
27. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.
Summers AM; Clancy MJ; Syed F; Harwood N; Brenchley PE; Augustine T; Riad H; Hutchison AJ; Taylor P; Pearson R; Gokal R
Kidney Int; 2005 Nov; 68(5):2381-8. PubMed ID: 16221244
[TBL] [Abstract][Full Text] [Related]
28. Cancer antigen 125 in patients with chronic liver disease.
Devarbhavi H; Kaese D; Williams AW; Rakela J; Klee GG; Kamath PS
Mayo Clin Proc; 2002 Jun; 77(6):538-41. PubMed ID: 12059123
[TBL] [Abstract][Full Text] [Related]
29. Outcome of an opportunistic infection after polymicrobial peritonitis in an HIV-infected patient treated with peritoneal dialysis.
Varela MP; Lew SQ; Smith AM; Whyte RL; Bosch JP
Am J Nephrol; 1999; 19(6):682-5. PubMed ID: 10592364
[TBL] [Abstract][Full Text] [Related]
30. Tuberculous peritonitis in chronic renal failure managed by continuous ambulatory peritoneal dialysis.
McKerrow KJ; Neale TJ
Aust N Z J Med; 1983 Aug; 13(4):343-7. PubMed ID: 6580857
[TBL] [Abstract][Full Text] [Related]
31. Innovations in Treatment Delivery, Risk of Peritonitis, and Patient Retention on Peritoneal Dialysis.
Piraino B
Semin Dial; 2017 Mar; 30(2):158-163. PubMed ID: 28066919
[TBL] [Abstract][Full Text] [Related]
32. Peritoneal Dialysis Use in Patients With Ascites: A Review.
Rajora N; De Gregorio L; Saxena R
Am J Kidney Dis; 2021 Nov; 78(5):728-735. PubMed ID: 34144102
[TBL] [Abstract][Full Text] [Related]
33. The impact of peritoneal permeability and residual renal function on PD prescription.
Harty J; Gokal R
Perit Dial Int; 1996; 16 Suppl 1():S147-52. PubMed ID: 8728182
[TBL] [Abstract][Full Text] [Related]
34. [Peritoneal dialysis in cirrhotic patients].
De Vecchi AF
G Ital Nefrol; 2009; 26(2):215-24. PubMed ID: 19382077
[TBL] [Abstract][Full Text] [Related]
35. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C
Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487
[TBL] [Abstract][Full Text] [Related]
36. Abdominal wall hernias in ESRD patients receiving peritoneal dialysis.
Suh H; Wadhwa NK; Cabralda T; Sokunbi D; Pinard B
Adv Perit Dial; 1994; 10():85-8. PubMed ID: 7999871
[TBL] [Abstract][Full Text] [Related]
37. Disturbed host defense in peritoneal cavity during CAPD: characterization of responsible factors in dwell fluid.
Vanholder R; Lameire N; Waterloos MA; Van Landschoot N; De Smet R; Vogeleere P; Lambert MC; Vijt D; Ringoir S
Kidney Int; 1996 Aug; 50(2):643-52. PubMed ID: 8840297
[TBL] [Abstract][Full Text] [Related]
38. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis.
Fernandez de Castro M; Selgas R; Jimenez C; Auxiliadora Bajo M; Martinez V; Romero JR; de Alvaro F; Vara F
Perit Dial Int; 1994; 14(3):265-70. PubMed ID: 7948240
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico.
Su-Hernández L; Abascal-Macías A; Méndez-Bueno FJ; Paniagua R; Amato D
Perit Dial Int; 1996; 16(4):362-5. PubMed ID: 8863327
[TBL] [Abstract][Full Text] [Related]
40. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
